Skip to main content
. 2018 Apr 19;13(4):e0196081. doi: 10.1371/journal.pone.0196081

Fig 5. Diagnostics performance of triplex miRNA panel in HCC patients with small tumors.

Fig 5

Diagnostic performance of the panel Mir@AFP based on the miRNAs miR-21, miR-122, miR-192 and AFP in differentiating hepatocellular carcinoma with small tumor size (<5 cm) from other groups. (A): HCC vs. CHB; (B): HCC vs. LC; (C): HCC vs. LC+CHB and (D): HCC vs. (LC+CHB+HC).